XPO1 inhibition as a clinically viable strategy to enhance durability of response to KRASG12D inhibitor in pancreatic ductal adenocarcinoma

被引：0
|
作者：
Al Hallak, Mohammed Najeeb
Khan, Husain Yar
Aboukameel, Amro
Bannoura, Sahar
Choucair, Khalil
Beal, Eliza W.
Tobon, Miguel
Beydoun, Rafic
Shields, Anthony F.
Mohammad, Ramzi
Beebe-Dimmer, Jennifer Lynn
Philip, Philip Agop
Pasche, Boris
Azmi, Asfar S.
机构：
[1] Wayne State Univ, Barbara Ann Karmanos Canc Inst, Detroit, MI USA
[2] Wayne State Univ, Detroit, MI USA
[3] Wayne State Univ, Henry Ford Canc Inst, Sch Med, Detroit, MI USA
[4] SWOG, Detroit, MI USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2025年 / 43卷 / 4_SUPPL期
基金：
美国国家卫生研究院;
关键词：
D O I：
10.1200/JCO.2025.43.4_suppl.736
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：736 / 736
页数：1
相关论文
共 50 条
  • [41] Characterization of a murine pancreatic ductal adenocarcinoma (PDAC) model with tamoxifen inducible pancreas-specific blockade of transforming growth factor-β (TGF-β) signaling with KrasG12D expression
    Pandey, Sanjay
    Bell, Brett
    Chavez, Claudia G.
    Koba, Wade
    Savage, Talicia
    Asp, Patrik
    Basu, Indranil
    Guha, Chandan
    CANCER RESEARCH, 2022, 82 (12)
  • [42] Combined cdk1 and PARP inhibition results in tumor regression in a KrasG12D p53L/L murine lung adenocarcinoma model
    Johnson, Neil
    Li, Yu-Chen
    Walton, Zandra
    Li, Danan
    Moreau, Lisa
    Rodig, Scott J.
    D'Andrea, Alan D.
    Thomas, Huw
    Newell, David R.
    Curtin, Nicola J.
    Wong, Kwok K.
    Shapiro, Geoffrey I.
    CANCER RESEARCH, 2011, 71
  • [43] Anticancer and therapeutic efficacy of XPO1 inhibition in pancreatic ductal adenocarcinoma through DNA damage and modulation of miR-193b/ KRAS/LAMC2/ERK/AKT signaling cascade
    Kirtonia, Anuradha
    Pandya, Gouri
    Singh, Aishwarya
    Kumari, Rachana
    Singh, Bhavana
    Kapoor, Sonia
    Khattar, Ekta
    Pandey, Amit Kumar
    Garg, Manoj
    LIFE SCIENCES, 2025, 362
  • [44] Phase II study of selumetinib, an orally active inhibitor of MEK1 and MEK2 kinases, in KRASG12R-mutant pancreatic ductal adenocarcinoma
    Kenney, Cara
    Kunst, Tricia
    Webb, Santhana
    Christina, Devisser, Jr.
    Arrowood, Christy
    Steinberg, Seth M.
    Mettu, Niharika B.
    Kim, Edward J.
    Rudloff, Udo
    INVESTIGATIONAL NEW DRUGS, 2021, 39 (03) : 821 - 828
  • [45] Differential sensitivity of mouse PDAC KrasG12D cells to Ref-1/APE1 redox signalling inhibitors: Role of NFkB as a primary target of Ref-1/APE1 in Kras driven pancreatic ductal adenocarcinoma.
    Caston, Rachel A.
    Wireman, Randy
    Armstrong, Lee
    Gampala, Silpa
    Babb, Olivia
    Chowdhury, Nayela
    Hassan, Zonera
    Schneeweis, Christian
    Schneider, Gunter
    Fishel, Melissa L.
    Kelley, Mark R.
    CANCER RESEARCH, 2021, 81 (13)
  • [46] Phase II study of selumetinib, an orally active inhibitor of MEK1 and MEK2 kinases, in KRASG12R-mutant pancreatic ductal adenocarcinoma
    Cara Kenney
    Tricia Kunst
    Santhana Webb
    Devisser Christina
    Christy Arrowood
    Seth M. Steinberg
    Niharika B. Mettu
    Edward J. Kim
    Udo Rudloff
    Investigational New Drugs, 2021, 39 : 821 - 828
  • [47] KRAS copy number variation and mutant allele fractions predict in vitro response of PDX-derived human pancreatic cancer cell lines to KRASG12D inhibitor MRTX1133
    Sarcar, Bhaswati
    Tassielli, Alexandra
    Wang, Liang
    Dai, Ruifan
    Read, Meagan D.
    Beato, Francisca
    Kim, Dae W.
    Hodul, Pamela J.
    Permuth, Jennifer B.
    Haura, Eric B.
    Malafa, Mokenge P.
    Fleming, Jason B.
    MOLECULAR CANCER RESEARCH, 2023, 21 (05)
  • [48] ATR Kinase Inhibition Leads to Durable Radiosensitization of the Murine KrasG12D/Twist1 Lung Adenocarcinoma Model via a CD8+ T Cell-Dependent Mechanism
    Karukonda, P.
    Vendetti, F. P.
    Tran, P. T.
    Clump, D. A.
    Ferris, R. L.
    Bakkenist, C. J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : S30 - S31
  • [49] Endogenous n-3 Polyunsaturated Fatty Acids Delay Progression of Pancreatic Ductal Adenocarcinoma in Fat-1-p48Cre/+-LSL-KrasG12D/+ Mice
    Mohammed, Altaf
    Janakiram, Naveena B.
    Brewer, Misty
    Duff, Ashley
    Lightfoot, Stan
    Brush, Richard S.
    Anderson, Robert E.
    Rao, Chinthalapally V.
    NEOPLASIA, 2012, 14 (12): : 1249 - +
  • [50] KrasG12D-Induced IKK2/β/NF-κB Activation by IL-1α and p62 Feedforward Loops Is Required for Development of Pancreatic Ductal Adenocarcinoma
    Ling, Jianhua
    Kang, Ya'an
    Zhao, Ruiying
    Xia, Qianghua
    Lee, Dung-Fang
    Chang, Zhe
    Li, Jin
    Peng, Bailu
    Fleming, Jason B.
    Wang, Huamin
    Liu, Jinsong
    Lemischka, Ihor R.
    Hung, Mien-Chie
    Chiao, Paul J.
    CANCER CELL, 2012, 21 (01) : 105 - 120
12345